Home » Topics » BioWorld Science

BioWorld Science
RSS

Now, Sleeping Beauty is the fairest of them all

Nov. 11, 2019

Glecaprevir/pibrentasvir investigated in young children with chronic HCV infection

Nov. 11, 2019

Zelluna Immunotherapy presents novel compound, ZI-H04, as cancer immunotherapeutic

Nov. 11, 2019

New DREADD tools for noninvasive manipulation and visualization of neuronal circuits in animals

Nov. 11, 2019

Novel AVV-based vector therapy for the treatment of AD

Nov. 11, 2019

Exosomes help brain metastases along

Nov. 11, 2019

Simpler recipe makes better cocktail for iPSCs

Nov. 11, 2019

Roche and Genentech identify new RIP-1 inhibitors

Nov. 11, 2019

Medshine Discovery patents Rho kinase inhibitors

Nov. 11, 2019

FORMA Therapeutics discovers histone deacetylase 11 inhibitors

Nov. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...